Sellas Life Sciences

OverviewSuggest Edit

SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. Its lead product candidate, galinpepimut-S (GPS), is a cancer immunotherapeutic agent that targets a spectrum of hematologic cancers and solid tumor indications. The company was formed as a result of a merger between Galena Biopharma and SELLAS Life Sciences Group Ltd.

TypePublic
Founded2006
HQNew York, US
Websitesellaslifesciences.com

Locations

Sellas Life Sciences is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Dec 2019)5(-37%)
Revenue (FY, 2017)$0(-100%)
Share Price (Jul 2020)$3 (+10%)
Cybersecurity ratingAMore

Sellas Life Sciences Office Locations

Sellas Life Sciences has an office in New York
New York, US (HQ)
15 W 38th St 10th floor
Show all (1)

Sellas Life Sciences Financials and Metrics

Sellas Life Sciences Revenue

USD

Net income (Q1, 2020)

(4.1m)

Market capitalization (7-Jul-2020)

20.4m

Closing stock price (7-Jul-2020)

3.0

Cash (31-Mar-2020)

6.7m

EV

14.0m
Sellas Life Sciences's current market capitalization is $20.4 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

2.5m9.3m

Cost of goods sold

520.0k1.4m

Gross profit

2.0m7.9m

Gross profit Margin, %

79%85%
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

1.2m2.2m2.3m1.6m2.8m3.4m

Cost of goods sold

301.0k331.0k347.0k247.0k393.0k468.0k

Gross profit

869.0k1.8m2.0m1.4m2.4m2.9m

Gross profit Margin, %

74%85%85%85%86%86%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

11.4m32.8m47.8m23.7m29.7m18.1m2.3m5.3m7.3m

Accounts Receivable

3.7m1.8m

Prepaid Expenses

276.0k535.0k1.4m2.7m1.4m581.0k337.0k387.0k557.0k

Inventories

386.0k655.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

17.9m15.7m8.7m19.2m15.4m17.5m20.9m51.4m52.4m39.2m24.6m52.9m45.3m34.7m19.6m24.5m27.6m18.1m12.9m3.5m1.3m10.0m2.6m12.8m9.1m6.7m

Accounts Receivable

1.5m1.5m2.2m1.4m1.1m1.8m6.6m

Prepaid Expenses

259.0k494.0k290.0k760.0k801.0k210.0k389.0k485.0k1.3m1.7m1.8m2.6m2.4m1.1m1.2m1.0m449.0k434.0k520.0k986.0k931.0k651.0k726.0k776.0k977.0k1.9m

Inventories

352.0k425.0k358.0k433.0k450.0k637.0k1.4m
USDQ2, 2011

Financial Leverage

3.3 x
Show all financial metrics

Sellas Life Sciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Sellas Life Sciences Online and Social Media Presence

Embed Graph

Sellas Life Sciences Frequently Asked Questions

  • When was Sellas Life Sciences founded?

    Sellas Life Sciences was founded in 2006.

  • How many employees does Sellas Life Sciences have?

    Sellas Life Sciences has 5 employees.

  • Who are Sellas Life Sciences competitors?

    Competitors of Sellas Life Sciences include Nektar Therapeutics, Ablynx and Karyopharm Therapeutics.

  • Where is Sellas Life Sciences headquarters?

    Sellas Life Sciences headquarters is located at 15 W 38th St 10th floor, New York.

  • Where are Sellas Life Sciences offices?

    Sellas Life Sciences has an office in New York.

  • How many offices does Sellas Life Sciences have?

    Sellas Life Sciences has 1 office.